Plaque psoriasis is the most common form of psoriasis, where red patches with a buildup of dead cells show up on your scalp, lower back, elbows & knees.

Medically reviewed by William Truswell, MD Medically reviewed by William Truswell, MD Psoriasis can be mild, moderate, or severe. Mild psoriasis means the disease affects less than 3% of the body ...

A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

Psoriasis is a chronic autoimmune condition that mainly affects the skin. When you have psoriasis, your immune system sends ...

Promising Psoriasis Pipeline Therapies such as Hypericin, EDP1815, Cetaphil, AX-158, HAT1 topical solution, Calcipotriol, ARQ ...

This segment is sponsored by Arcutis Biotherapeutics.Nearly 9 million people in the U.S. have an inflammatory skin condition ...

AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque psoriasis, Artax Biopharma announced in a press release. “[These ...

Arcutis announces FDA approval of ZORYVE foam for treating plaque psoriasis, offering rapid itch relief with no duration limits.

Turmeric is popular in Eastern medicine and is thought to have powerful anti-inflammatory abilities that may help psoriasis symptoms. But what does the research say about turmeric for psoriasis?

Early biologic response patterns in plaque psoriasis revealed faster remission with anti-IL-17AF and underscored the need for tailored treatment strategies.

Tapinarof cream was approved in May 2022 for treatment of mild, moderate, or severe plaque psoriasis in adults.